Asahi Intecc will be Exclusive Japanese Provider of the SoundBite™ Crossing System – Peripheral
MONTREAL – December 3, 2019 – SoundBite Medical Solutions Inc. (SBMS) has signed an exclusive distribution agreement with Asahi Intecc Co., Ltd. (“Asahi Intecc”) to sell its SoundBiteTM Crossing System in Japan.
Asahi Intecc is recognized globally as a leading manufacturer and provider of guidewires and catheters among other medical devices used by hospitals for cardiovascular interventions in over 108 countries and regions across the globe.
“We are excited to build on our strategic partnership with Asahi Intecc and to bring the SoundBite system to patients suffering from peripheral vascular disease in Japan. We look forward to this collaboration and to leveraging Asahi Intecc’s market leadership and experience to expand our reach and establish our innovative technology in this important market,” said Ashkan Haghighat, Vice-President, Business and Corporate Development at SBMS.
“This important distribution agreement with one of the most respected manufacturers of guidewires is further evidence of the enthusiasm SoundBite’s technology is creating in the vascular cardiology industry,” said Francis Bellido, CEO of SBMS. “Under Asahi Intecc’s guidance and strong local presence, we believe to now have all the resources necessary to create a great success story in Japan.”
“We are very pleased to bring the innovative device developed by SoundBite to the Japanese peripheral vascular market. We believe that a strong synergy effect will be generated between Asahi Intecc brand’s long-standing reputation for high quality and high performance in the Japanese market and SoundBite’s innovative product and technology. The SoundBite system is very effective for calcified lesions that continue to pose a major treatment challenge, often due to conventional guidewires failing to cross the lesion. We anticipate that the system will contribute to saving many patients that otherwise would not have been treatable.” said Masahiko Miyata, President and CEO, Asahi Intecc Co., Ltd.
The SoundBite™ Crossing System – Peripheral is used to facilitate the intra-luminal placement of conventional guidewires or treatment devices beyond peripheral artery chronic total occlusions. The SoundBite™ Crossing System – Peripheral consists of a re-usable console, the SoundBite™ Console, and a disposable wire, the SoundBite™ Active Wire.
About SoundBite Medical Solutions Inc.
SoundBite Medical Solutions Inc. is developing proprietary shock wave technology to address significant unmet clinical needs in interventional vascular treatment. Through an elegant combination of hardware and software, it can, in a very controllable manner, deliver high amplitude shock wave pulses through guidewires and other interventional tools, to specifically attack highly calcified and fibrotic tissue in the vascular system, while leaving healthy, elastic arterial walls unharmed.
For information on SoundBite Medical Solutions, please contact Mandy Di Lazzaro, Director, Human Resources & Communications (email@example.com) or Francis Bellido, CEO (firstname.lastname@example.org), SoundBite Medical Solutions, 2300 Alfred Nobel, Technoparc St-Laurent, Montreal Québec H4S 2A4
For additional information visit www.soundbitemedical.com
This press release contains forward-looking statements and forward-looking information, or, collectively, forward-looking statements, within the meaning of applicable securities laws, that are based on our management’s belief and assumptions and on information currently available to our management. You can identify forward-looking statements by terms such as “may”, “will”, “should”, “could”, “would”, “outlook”, “believe”, “plan”, “envisage”, “anticipate”, “expect” and “estimate” or the negatives of these terms, or variations of them. Forward-looking statements are based upon a number of assumptions and are subject to a number of risks and uncertainties, many of which are beyond SoundBite Medical Solutions Inc.’s control that could cause actual results to differ materially from those that are disclosed in or implied by such forward-looking information. The reader is cautioned to consider these and other risks and uncertainties carefully and not to put undue reliance on forward looking statements. Forward-looking statements reflect current expectations regarding future events and speak only as of the date of this press release and represent our expectations as of that date. We undertake no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances.